Richard Benson

Papers

Total Citations

H-Index

About

Richard Benson is a leading surgical oncologist whose research focuses on the optimal treatment of oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of the rising incidence of human papillomavirus (HPV)-associated disease. His major contribution lies in rigorously comparing minimally invasive surgical approaches—such as transoral robotic surgery (TORS) and transoral laser microsurgery—against radiotherapy and chemoradiotherapy for early-stage and small-volume primary oropharyngeal tumors. His most cited work (2016, 82 citations) provides critical evidence on outcomes for this younger, often higher-stage patient population, helping to shape clinical decision-making between surgical and non-surgical modalities. Benson’s research addresses a pressing oncologic challenge: balancing effective tumor control with quality of life in HPV-positive patients. His 2014 Cochrane protocol further underscores his commitment to evidence-based medicine, establishing a framework for systematic review in this rapidly evolving field. Through these contributions, Benson has influenced treatment paradigms for oropharyngeal cancer, offering clinicians and patients clearer guidance on the trade-offs between surgery and radiation-based therapies.